Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenyi Wu

Showing results (1-10 of 100) with videos related to

Pageof 10
Sort By:
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|January 14, 2015
[Research progress of anti-angiogenesis drug targets in diabetic retinopathy]Wenyi Wu, Luosheng Tang
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|January 27, 2015
[Research progress of vascular endothelial tip cells in diabetic retinopathy]Wenyi Wu, Luosheng Tang
Methods in Molecular Biology (Clifton, N.J.)|June 16, 2023
Genome Editing Inhibits Retinal Angiogenesis in a Mouse Model of Oxygen-Induced RetinopathyWenyi Wu, Hetian Lei
BMC Medical Education|May 10, 2024
Assessing the impact of Medical Education's Innovation & Entrepreneurship Program in ChinaXiandi You, Wenyi Wu
Medicinal Research Reviews|September 2, 2018
Progress in the application of CRISPR: From gene to base editingWenyi Wu, Yanhui Yang, Hetian Lei
Frontiers in Immunology|September 15, 2025
Reduced-dose obinutuzumab induces remission in refractory ANCA-associated vasculitis: a report of 16 casesWenyi Wu, Juan Wang, Sheng Chen
Plos One|November 5, 2024
Does CEO social capital affect corporate ESG performance?Wenyi Wu, Zhaoping Tian, Guangzhi Wang
BMC Rheumatology|November 29, 2025
Rituximab vs. Cyclophosphamide induction therapy for patients with ANCA-associated vasculitisWenyi Wu, Juan Wang, Sheng Chen
Discovery Medicine|July 18, 2017
The role of netrin-1 in angiogenesis and diabetic retinopathy: a promising therapeutic strategyWenyi Wu, Hetian Lei, Junhui Shen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 2, 2023
Nintedanib inhibits normal human vitreous-induced epithelial-mesenchymal transition in human retinal pigment epithelial cellsYiwei Yin, Shikun Liu, Hanhan Liu, et al.
Pageof 10

Showing results (1-10 of 100) with videos related to

Sort By:
Pageof 10
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|January 14, 2015
[Research progress of anti-angiogenesis drug targets in diabetic retinopathy]Wenyi Wu, Luosheng Tang
[Zhonghua Yan Ke Za Zhi] Chinese Journal of Ophthalmology|January 27, 2015
[Research progress of vascular endothelial tip cells in diabetic retinopathy]Wenyi Wu, Luosheng Tang
Methods in Molecular Biology (Clifton, N.J.)|June 16, 2023
Genome Editing Inhibits Retinal Angiogenesis in a Mouse Model of Oxygen-Induced RetinopathyWenyi Wu, Hetian Lei
BMC Medical Education|May 10, 2024
Assessing the impact of Medical Education's Innovation & Entrepreneurship Program in ChinaXiandi You, Wenyi Wu
Medicinal Research Reviews|September 2, 2018
Progress in the application of CRISPR: From gene to base editingWenyi Wu, Yanhui Yang, Hetian Lei
Frontiers in Immunology|September 15, 2025
Reduced-dose obinutuzumab induces remission in refractory ANCA-associated vasculitis: a report of 16 casesWenyi Wu, Juan Wang, Sheng Chen
Plos One|November 5, 2024
Does CEO social capital affect corporate ESG performance?Wenyi Wu, Zhaoping Tian, Guangzhi Wang
BMC Rheumatology|November 29, 2025
Rituximab vs. Cyclophosphamide induction therapy for patients with ANCA-associated vasculitisWenyi Wu, Juan Wang, Sheng Chen
Discovery Medicine|July 18, 2017
The role of netrin-1 in angiogenesis and diabetic retinopathy: a promising therapeutic strategyWenyi Wu, Hetian Lei, Junhui Shen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 2, 2023
Nintedanib inhibits normal human vitreous-induced epithelial-mesenchymal transition in human retinal pigment epithelial cellsYiwei Yin, Shikun Liu, Hanhan Liu, et al.
Pageof 10